Sriram Venkataraman Insider Trading
Get free email notifications about insider trading for Sriram Venkataraman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sriram Venkataraman. Sriram Venkataraman is a Director in OptiNose, Inc. ($OPTN) and a Director in Lantheus Holdings, Inc. ($LNTH) and a Director in Osmotica Pharmaceuticals plc ($OSMT).
Address: C/O AVISTA CAPITAL PARTNERS 65 E. 55TH STREET, 18TH FLOOR NEW YORK 10022 NY
Companies in which Sriram Venkataraman is an Insider
Lantheus Holdings, Inc.
Trading Symbol: LNTHIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Sriram Venkataraman: Director
Holdings: 7,004,395 shares
Current Value: $63,039,555
Latest Transaction: Mar 21 2017
$LNTH Market Capitalization: $323.30M
$LNTH Previous Close: $9.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OptiNose, Inc.
Trading Symbol: OPTNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sriram Venkataraman: Director
Holdings: 10,136,374 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Osmotica Pharmaceuticals plc
Trading Symbol: OSMTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sriram Venkataraman: Director
Holdings: 0 shares
Latest Transaction: Nov 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sriram Venkataraman
Sentiment: All, LNTH, OPTN, OSMT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 23 2020 | OSMT | Osmotica Pharmaceu ... | Venkataraman Sriram | Director | Sell | J | 0.00 | 4,936,926 | 0 | 0 | 4.9 M to 0 (-100.00 %) |
Jun 12 2020 | OPTN | OptiNose, Inc. | Venkataraman Sriram | Director | Option Exercise | A | 5.65 | 14,439 | 81,580 | 14,439 | |
Jan 15 2020 | OSMT | Osmotica Pharmaceu ... | Venkataraman Sriram | Director | Buy | P | 5.00 | 1,250,000 | 6,250,000 | 15,730,864 | 14.5 M to 15.7 M (+8.63 %) |
Nov 26 2019 | OPTN | OptiNose, Inc. | Venkataraman Sriram | Director | Sell | S | 9.17 | 70,762 | 648,534 | 807,995 | 878.8 K to 808 K (-8.05 %) |
Nov 26 2019 | OPTN | OptiNose, Inc. | Venkataraman Sriram | Director | Sell | S | 9.17 | 291,516 | 2,671,744 | 3,328,648 | 3.6 M to 3.3 M (-8.05 %) |
Nov 26 2019 | OPTN | OptiNose, Inc. | Venkataraman Sriram | Director | Sell | S | 9.17 | 887,722 | 8,135,972 | 10,136,374 | 11 M to 10.1 M (-8.05 %) |
Jun 10 2019 | OPTN | OptiNose, Inc. | Venkataraman Sriram | Director | Option Exercise | A | 6.60 | 14,439 | 95,297 | 14,439 |